W H Wilson Tang Selected Research

Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)

1/2020	Measures of Loop Diuretic Efficiency and Prognosis in Chronic Kidney Disease.
1/2020	Sodium-Glucose Cotransporter-2 Inhibitors and Loop Diuretics for Heart Failure: Priming the Natriuretic and Metabolic Reserve of the Kidney.
8/2018	Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low.
7/2018	Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
1/2018	Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF.
1/2018	Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
8/2017	An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.
2/2016	Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
1/2016	Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights.
1/2016	Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W H Wilson Tang Research Topics

Disease

269	Heart Failure 10/2022 - 01/2002
42	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2002
28	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 06/2009
27	Myocardial Infarction 01/2022 - 12/2002
26	Systolic Heart Failure 12/2017 - 12/2003
22	Inflammation (Inflammations) 01/2022 - 08/2008
20	Cardiomyopathies (Cardiomyopathy) 10/2022 - 01/2007
20	Stroke (Strokes) 01/2022 - 01/2007
20	Atherosclerosis 01/2021 - 01/2011
16	Neoplasms (Cancer) 01/2022 - 05/2010
15	Acute Coronary Syndrome 01/2022 - 12/2002
14	Left Ventricular Dysfunction 01/2022 - 12/2005
14	Fibrosis (Cirrhosis) 01/2021 - 06/2006
14	Chronic Renal Insufficiency 01/2021 - 11/2012
14	Death (Near-Death Experience) 06/2017 - 06/2007
12	Thrombosis (Thrombus) 01/2022 - 09/2012
11	Weight Loss (Weight Reduction) 11/2020 - 01/2012
11	Renal Insufficiency (Renal Failure) 07/2018 - 12/2002
10	Hypertension (High Blood Pressure) 01/2021 - 05/2010
10	Heart Diseases (Heart Disease) 01/2021 - 04/2011
10	Obesity 01/2021 - 01/2013
10	Ventricular Remodeling 01/2020 - 01/2003
9	Atrial Fibrillation 11/2020 - 07/2004
8	Diabetes Mellitus 01/2019 - 01/2004
7	Cardio-Renal Syndrome 01/2021 - 01/2016
7	Atherosclerotic Plaque (Atheroma) 01/2020 - 11/2012
7	Pulmonary Arterial Hypertension 01/2018 - 03/2011
7	Hyponatremia 01/2017 - 06/2006
6	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2013
6	Cardiotoxicity 01/2022 - 02/2012
6	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2020 - 07/2004
6	Anemia 01/2018 - 02/2008
6	Bundle-Branch Block (Fascicular Block) 10/2017 - 05/2006
5	Amyloidosis 10/2022 - 04/2014
5	Pulmonary Hypertension 10/2021 - 03/2012
5	Infections 01/2021 - 05/2006
5	Insulin Resistance 01/2021 - 07/2004
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 02/2011
5	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 11/2012
5	Infarction (Infarctions) 06/2017 - 01/2003
5	Dyspnea (Shortness of Breath) 01/2016 - 05/2014
4	Coronary Disease (Coronary Heart Disease) 01/2022 - 12/2014
4	Hypertrophy 10/2021 - 06/2006

Drug/Important Bio-Agent (IBA)

49	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2003
43	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022 - 04/2011
34	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2021 - 12/2003
31	DiureticsIBA 01/2021 - 06/2006
22	Natriuretic PeptidesIBA 01/2022 - 07/2006
22	CreatinineIBA 01/2021 - 08/2008
20	Peroxidase (Myeloperoxidase)IBA 10/2021 - 09/2006
19	Choline (Choline Chloride)IBA 01/2022 - 04/2011
18	SodiumIBA 11/2021 - 11/2012
18	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2020 - 06/2013
12	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 12/2005
12	pro-brain natriuretic peptide (1-76)IBA 09/2019 - 01/2007
11	omega-Chloroacetophenone (Mace)IBA 01/2022 - 06/2009
11	Proteins (Proteins, Gene)FDA Link 08/2020 - 01/2011
11	TroponinIBA 05/2020 - 12/2002
11	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2020 - 04/2011
10	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022 - 05/2013
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2004
10	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 01/2003
10	trimethylamineIBA 01/2020 - 05/2013
10	ChloridesIBA 10/2018 - 09/2014
10	C-Reactive ProteinIBA 01/2017 - 02/2008
9	Urea (Carbamide)FDA LinkGeneric 01/2019 - 04/2013
9	Hemoglobins (Hemoglobin)IBA 02/2017 - 02/2008
9	Oxidants (Oxidizing Agents)IBA 06/2014 - 03/2010
8	Cystatin CIBA 01/2021 - 06/2008
7	IronIBA 01/2022 - 01/2007
7	Aryldialkylphosphatase (Paraoxonase)IBA 01/2022 - 01/2011
7	Troponin IIBA 08/2018 - 12/2002
7	Pharmaceutical PreparationsIBA 10/2016 - 04/2003
7	NitrogenIBA 09/2016 - 11/2012
6	Amyloid (Amyloid Fibrils)IBA 10/2022 - 04/2014
6	arylesteraseIBA 01/2022 - 03/2010
6	AnthracyclinesIBA 01/2022 - 01/2014
6	Vasodilator Agents (Vasodilators)IBA 10/2021 - 01/2008
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2017 - 12/2005
6	AntioxidantsIBA 01/2017 - 03/2010
6	Furosemide (Lasix)FDA LinkGeneric 02/2016 - 11/2012
6	Eplerenone (Inspra)FDA LinkGeneric 09/2012 - 01/2003
5	LipidsIBA 01/2022 - 10/2013
5	AldosteroneIBA 01/2020 - 12/2005
5	Arginine (L-Arginine)FDA Link 07/2017 - 06/2009
5	EnzymesIBA 06/2017 - 01/2005
5	HDL LipoproteinsIBA 01/2017 - 01/2011
5	Betaine (C.B.B.)FDA Link 01/2017 - 04/2011
5	Ceruloplasmin (Ferroxidase)IBA 12/2014 - 03/2010
5	Lipocalin-2IBA 09/2013 - 01/2010
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 05/2010

Therapy/Procedure

102	Therapeutics 10/2022 - 01/2002
34	Cardiac Resynchronization Therapy 01/2022 - 01/2007
18	Transplantation 01/2022 - 06/2007
14	Patient Readmission 01/2021 - 03/2008
9	Heart-Assist Devices 10/2021 - 05/2010
8	Length of Stay 01/2015 - 07/2004
7	Heart Transplantation (Grafting, Heart) 01/2021 - 05/2008
6	Drug Therapy (Chemotherapy) 01/2022 - 11/2003
6	Glycemic Control 01/2017 - 01/2006